Company News in the Life Science Industry

Reset 

Live Town Hall Series - Supporting Mental Health in Communities of Color: Ways Forward

NEW YORK, July 7, 2020 /PRNewswire/ -- The nation's largest suicide prevention organization, the American Foundation for Suicide Prevention, is hosting a virtual town hall series on Elevating Voices for Long-Lasting Change to address the mental health and suicide prevention needs of... Read more ››

By: PR Newswire Association LLC. - 07 Jul 2020

Arthroscopic Techniques Developed At Crystal Clinic Orthopaedic Center Are Now Used Worldwide In Orthopaedic Surgery

FAIRLAWN, Ohio, July 7, 2020 /PRNewswire/ -- Orthopaedic surgeons at Crystal Clinic Orthopaedic Center are at the forefront of developing advanced, minimally invasive techniques for patients and providing training to other surgeons around the globe in their use. Among the latest arthroscopic... Read more ››

By: PR Newswire Association LLC. - 07 Jul 2020

FDA Approves New Therapy for Myelodysplastic Syndromes (MDS) That Can Be Taken at Home

SILVER SPRING, Md., July 7, 2020 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Inqovi (decitabine and cedazuridine) tablets for treatment of adult patients with myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML). This represents an important advance... Read more ››

By: PR Newswire Association LLC. - 07 Jul 2020
Related companies:  U.S. Food and Drug Administration

Aesculap Implant Systems Announces New Positive Third-Party Clinical Guidelines that May Introduce Access for More than 8.5 Million Commercially Insured Americans to the activL® Artificial Disc

CENTER VALLEY, Pa., July 7, 2020 /PRNewswire/ -- Aesculap Implant Systems, LLC today announced that National Imaging Associates (NIA), a Magellan Health Company, has updated its "Clinical Guidelines for Medical Necessity for Musculoskeletal and Surgery" to include a medical necessity recommendation... Read more ››

By: PR Newswire Association LLC. - 07 Jul 2020
Related companies:  Aesculap Implant Systems

$10+ Billion Worldwide Cell Counting Industry to 2025 - Featuring Abbott Laboratories, Perkinelmer & Agilent Technologies Among Others

DUBLIN, July 7, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 07 Jul 2020

Sandoz collaborates with Civica Rx to help reduce critical generic medicine shortages in US hospitals

PRINCETON, N.J., July 7, 2020 /PRNewswire/ -- Sandoz Inc. today announced it has entered into a long-term agreement with Civica Rx (Civica, Inc.) to manufacture and supply critical injectable generic medicines, to help reduce supply shortages and ensure acute care settings can deliver optimal... Read more ››

By: PR Newswire Association LLC. - 07 Jul 2020
Related companies:  Civica Rx

Hydrofera, Aroa Provide Free APPULSE Home Care Protocol for Treatment of Wounds in the Home Care Setting

MANCHESTER, Conn., July 7, 2020 /PRNewswire/ -- Hydrofera LLC, manufacturer of a complete line of wound care dressings, together with Aroa, has produced the "APPULSE Wound Care Protocol for Home Health Care," which also includes the Endoform Extracellular Matrix to further aid in the healing... Read more ››

By: PR Newswire Association LLC. - 07 Jul 2020

Avantor® Announces Upsizing and Pricing of Offering of $2.0 Billion Equivalent of Senior Notes

RADNOR, Pa., July 7, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR) ("Avantor"), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced today the pricing of the previously announced... Read more ››

By: PR Newswire Association LLC. - 07 Jul 2020

ROSEN, GLOBAL INVESTOR COUNSEL, Reminds CytomX Therapeutics, Inc. Investors of Important Deadline in Securities Class Action - CTMX

NEW YORK, July 7, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of CytomX Therapeutics, Inc. (NASDAQ: CTMX) between May 17, 2018, and May 13, 2020, inclusive (the "Class Period"), of the important July 20, 2020 lead plaintiff deadline... Read more ››

By: PR Newswire Association LLC. - 07 Jul 2020
Related companies:  CytomX Therapeutics, Inc.

Update on Mental Wellness Supports for those impacted by MMIWG and the Federal Indian Day Schools Settlement Agreement

OTTAWA, TRADITIONAL ALGONQUIN TERRITORY, ON, July 7, 2020 /CNW/ - The Government of Canada recognizes the lasting impact of colonial policies and persistent discrimination on the lives of many First Nations, Inuit and Métis individuals, their families and communities. Many have to carry the... Read more ››

By: PR Newswire Association LLC. - 07 Jul 2020

Reata Announces Promotion and New Hires For Key Leadership Roles

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  Reata Pharmaceuticals, Inc.

Annovis Bio Receives Institutional Review Board Approval to Initiate 15 Site Phase 2 Study in 68 Parkinson’s and Alzheimer’s Patients

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  Annovis Bio, Inc.

Tonix Pharmaceuticals Plans Massachusetts R&D Facility to Accelerate Clinical Development of Vaccines and Protein-Based Therapeutics

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  Tonix Pharmaceuticals Holding Corp.

Corvus Pharmaceuticals Initiates Clinical Trial of Novel Immunotherapy for Patients with COVID-19

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  Corvus Pharmaceuticals, Inc.

Nasus Pharma Announces Data Demonstrating Efficacy of TaffiX® Intranasal Antiviral Protection Against SARS-CoV-2

Read more ››
By: GlobenewsWire - 07 Jul 2020

DLT Resolution Successfully Deployed Its Vote YourChoice™ Secure Online & Remote Voting Application for Manufacturing Union Election

Read more ››
By: GlobenewsWire - 07 Jul 2020

Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA)

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  Apellis Pharmaceuticals, Inc.

Cybrexa Therapeutics Completes Successful Pre-IND Meeting With FDA for CBX-12 (alphalex™-exatecan), a Novel Treatment for Solid Tumors

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  Cybrexa Therapeutics

BioXcel Therapeutics Announces Notice of Allowance for U.S. Patent Application Covering Formulation for BXCL501 and Methods of Treating Agitation

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  BioXcel Therapeutics, Inc.

Major Shareholder Announcement

Read more ››
By: GlobenewsWire - 07 Jul 2020
Related companies:  Genmab A/S
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25

Explore our database of over 50,000 companies